Morgan Stanley Ligand Pharmaceuticals Inc Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Morgan Stanley holds 237,013 shares of LGND stock, worth $26.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

237,013

Previous 194,338 21.96%

Holding current value

$26.4 Million

Previous $16.4 Million 44.99%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$82.7 - $110.11 $3.53 Million - $4.7 Million	42,675 Added 21.96%	237,013 $23.7 Million
Q2 2024 Oct 17, 2024	SELL	$68.53 - $87.91 $3.94 Million - $5.06 Million	-57,559 Reduced 22.85%	194,338 $16.4 Million
Q2 2024 Aug 14, 2024	SELL	$68.53 - $87.91 $3.94 Million - $5.06 Million	-57,559 Reduced 22.85%	194,338 $16.4 Million
Q1 2024 Oct 17, 2024	BUY	$68.64 - $89.2 $3.95 Million - $5.13 Million	57,559 Added 29.62%	251,897 $18.4 Million
Q1 2024 Aug 16, 2024	BUY	$68.64 - $89.2 $3.62 Million - $4.7 Million	52,703 Added 26.46%	251,897 $18.4 Million
Q1 2024 May 15, 2024	BUY	$68.64 - $89.2 $3.62 Million - $4.7 Million	52,703 Added 26.46%	251,897 $18.4 Million
Q4 2023 Aug 16, 2024	BUY	$49.57 - $72.63 $240,711 - $352,691	4,856 Added 2.5%	199,194 $14.2 Million
Q4 2023 Feb 13, 2024	BUY	$49.57 - $72.63 $207,549 - $304,101	4,187 Added 2.15%	199,194 $14.2 Million
Q3 2023 Nov 15, 2023	BUY	$58.86 - $72.67 $1.57 Million - $1.94 Million	26,741 Added 15.89%	195,007 $11.7 Million
Q2 2023 Aug 14, 2023	BUY	$69.53 - $79.33 $916,892 - $1.05 Million	13,187 Added 8.5%	168,266 $12.1 Million
Q1 2023 May 15, 2023	SELL	$65.67 - $77.08 $1.94 Million - $2.27 Million	-29,491 Reduced 15.98%	155,079 $11.4 Million
Q4 2022 Feb 14, 2023	BUY	$61.72 - $96.74 $3.96 Million - $6.2 Million	64,106 Added 53.22%	184,570 $12.3 Million
Q3 2022 Nov 14, 2022	SELL	$0.01 - $107.56 $277 - $2.98 Million	-27,747 Reduced 18.72%	120,464 $10.4 Million
Q2 2022 Oct 27, 2022	BUY	$74.52 - $117.06 $420,516 - $660,569	5,643 Added 3.96%	148,211 $13.2 Million
Q2 2022 Aug 15, 2022	BUY	$74.52 - $117.06 $420,516 - $660,569	5,643 Added 3.96%	148,211 $13.2 Million
Q1 2022 Oct 27, 2022	SELL	$94.99 - $151.56 $536,028 - $855,253	-5,643 Reduced 3.81%	142,568 $16 Million
Q1 2022 May 13, 2022	BUY	$94.99 - $151.56 $6.14 Million - $9.8 Million	64,635 Added 82.94%	142,568 $16 Million
Q4 2021 Feb 14, 2022	SELL	$127.69 - $165.85 $2.25 Million - $2.92 Million	-17,629 Reduced 18.45%	77,933 $12 Million
Q3 2021 Nov 15, 2021	BUY	$102.33 - $144.73 $9.78 Million - $13.8 Million	95,562 New	95,562 $13.3 Million

Others Institutions Holding LGND

# of Institutions

257

Shares Held

18.2M

Call Options Held

26.8K

Put Options Held

9.3K

View Full List

About LIGAND PHARMACEUTICALS INC

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

More about LGND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account